Publications by Johan Tausjø
35 publications found
Original articles
Adequacy of Pathologic Reports of Invasive Breast Cancer From Mastectomy Specimens at Tikur Anbessa Specialized Hospital Oncology Center in Ethiopia
J Glob Oncol, 4, 1-12
DOI 10.1200/JGO.17.00198, PubMed 30084708
[Treatment of metastatic malignant melanoma localized to an extremity]
Tidsskr Nor Laegeforen, 130 (1), 21-4
DOI 10.4045/tidsskr.09.0701, PubMed 20094118
Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma
Nutr Cancer, 62 (3), 322-8
DOI 10.1080/01635580903441188, PubMed 20358469
Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma
Cancer Lett, 238 (2), 240-7
DOI 10.1016/j.canlet.2005.07.027, PubMed 16157445
External beam irradiation therapy for choroidal haemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy
Acta Ophthalmol Scand, 79 (2), 184-6
DOI 10.1034/j.1600-0420.2001.079002184.x, PubMed 11284760
Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources
Photochem Photobiol, 71 (6), 724-9
DOI 10.1562/0031-8655(2000)071<0724:ptosbc>2.0.co;2, PubMed 10857368
Bilateral diffuse uveal melanocytic proliferation and uterine cancer. A case report
Acta Ophthalmol Scand, 78 (3), 366-8
DOI 10.1034/j.1600-0420.2000.078003366.x, PubMed 10893075
Photodynamic therapy of residual or recurrent basal cell carcinoma after radiotherapy using topical 5-aminolevulinic acid or methylester aminolevulinic acid
Acta Oncol, 39 (5), 605-9
DOI 10.1080/028418600750013285, PubMed 11093368
Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study
Acta Derm Venereol, 79 (3), 204-6
DOI 10.1080/000155599750010977, PubMed 10384917
Survival of patients with squamous cell carcinoma of the supraglottic larynx--thirty-five-year experience with radiotherapy
Acta Oncol, 38 (7), 961-8
DOI 10.1080/028418699432662, PubMed 10606427
Recurrence after different primary treatment for cancer of the supraglottic larynx
Acta Oncol, 37 (2), 167-73
DOI 10.1080/028418698429720, PubMed 9636011
[Treatment of planocellular carcinoma of the nasal vestibule]
Tidsskr Nor Laegeforen, 117 (22), 3197-200
PubMed 9411856
Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study
Radiother Oncol, 43 (1), 23-8
DOI 10.1016/s0167-8140(97)01922-1, PubMed 9165133
External radiotherapy for circumscribed choroidal haemangiomas using a modified retinoblastoma technique
Acta Ophthalmol Scand, 73 (6), 547-50
DOI 10.1111/j.1600-0420.1995.tb00335.x, PubMed 9019383
Fistulae following laryngectomy in patients treated with irradiation
J Laryngol Otol, 107 (12), 1136-9
DOI 10.1017/s0022215100125484, PubMed 8289003
The value of follow-up in patients treated for squamous cell carcinoma of the head and neck
Eur J Cancer, 28 (2-3), 426-30
DOI 10.1016/s0959-8049(05)80068-1, PubMed 1591057
Elective radiotherapy of the neck in patients with squamous cell carcinoma of the head and neck
ORL J Otorhinolaryngol Relat Spec, 54 (2), 103-7
DOI 10.1159/000276274, PubMed 1614684
Combined radiotherapy and surgery in the treatment of neck node metastases from squamous cell carcinoma of the head and neck
Acta Oncol, 31 (4), 455-60
DOI 10.3109/02841869209088289, PubMed 1632982
Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma
Eur J Cancer, 27 (5), 576-9
DOI 10.1016/0277-5379(91)90221-x, PubMed 1828964
[Patients dying in institutions. A medical and human challenge]
Tidsskr Nor Laegeforen, 110 (17), 2233-5
PubMed 2375014
Primary irradiation, surgery or combined therapy in squamous cell carcinoma of the larynx. A comparison of treatment results from two centers
Acta Oncol, 29 (4), 489-503
DOI 10.3109/02841869009090038, PubMed 2202342
Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization
Scand J Gastroenterol, 24 (7), 787-95
DOI 10.3109/00365528909089215, PubMed 2477894
Computed tomography in T1 carcinoma of the larynx
Acta Radiol, 30 (5), 467-9
PubMed 2611050
Recombinant alpha-2 interferon with or without hepatic artery embolization in the treatment of midgut carcinoid tumours. A preliminary report
Acta Oncol, 28 (3), 439-43
DOI 10.3109/02841868909111219, PubMed 2742781
TREATMENT OF T3 LARYNGEAL CARCINOMA - CLINICAL-EVALUATION AFTER 50-GY, IS IT OF ANY VALUE
Acta Oto-Laryngol. (449), 141-144
Treatment of T3 laryngeal carcinoma. Clinical evaluation after 50 Gy, is it of any value?
Acta Otolaryngol Suppl, 449, 141-4
DOI 10.3109/00016488809106397, PubMed 3201940
[Treatment with Cis-platin. Retinal toxic effects]
Tidsskr Nor Laegeforen, 107 (15), 1346-8
PubMed 3603502
Changing aspects in the treatment of squamous cell carcinoma of the oral tongue
Acta Oncol, 26 (3), 163-72
DOI 10.3109/02841868709091424, PubMed 3651261
[Roentgentherapy of warts]
Tidsskr Nor Laegeforen, 106 (13), 1123-4
PubMed 3523827
[Small cell carcinoma of the lung. Combined therapy with cytostatics]
Tidsskr Nor Laegeforen, 105 (28), 1956-8
PubMed 3000018
[Induction therapy in small cell lung carcinoma]
Tidsskr Nor Laegeforen, 105 (28), 1974-7
PubMed 3000019
[Radiotherapy with intra-arterial chemotherapy. Treatment with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide. Effect in malignant melanoma of the extremities]
Tidsskr Nor Laegeforen, 105 (24), 1617-9
PubMed 4060116
Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck
J Otolaryngol, 14 (4), 211-4
PubMed 4057330
[Mithramycin in advanced malignant testicular tumors]
Tidsskr Nor Laegeforen, 95 (1), 23-8
PubMed 163041
Other articles
Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity
Cancer Treat Rep, 70 (8), 1015-7
PubMed 3731146